Barclays
JBIO

Barclays’s Jade Biosciences JBIO Stock Holding History

Barclays’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$346K Sell
24,660
-47,534
-66% -$688K ﹤0.01% 3388
2025
Q4 		$1.11M Buy
72,194
+26,427
+58% +$310K ﹤0.01% 3355
2025
Q3 		$395K Sell
45,767
-229,063
-83% -$1.87M ﹤0.01% 3950
2025
Q2 		$2.75M Buy
274,830
+274,413
+65,806% +$9.34M ﹤0.01% 2598
2025
Q1 		$36.7K Sell
417
-195
-32% -$17.1K ﹤0.01% 4681
2024
Q4 		$56.8K Buy
612
+70
+13% +$6.03K ﹤0.01% 4729
2024
Q3 		$39.7K Buy
542
+410
+311% +$26.4K ﹤0.01% 4795
2024
Q2 		$7.67K Sell
132
-93
-41% -$61.7K ﹤0.01% 4542
2024
Q1 		$233K Sell
225
-215
-49% -$164K ﹤0.01% 4039
2023
Q4 		$348K Buy
440
+330
+300% +$168K ﹤0.01% 4111
2023
Q3 		$52.2K Buy
110
+13
+13% +$7.04K ﹤0.01% 3849
2023
Q2 		$58.4K Sell
97
-38
-28% -$24.3K ﹤0.01% 3772
2023
Q1 		$95.2K Buy
135
+24
+22% +$19.9K ﹤0.01% 4210
2022
Q4 		$113K Buy
111
+100
+909% +$72.6K ﹤0.01% 4153
2022
Q3 		$6K Sell
11
-104
-90% -$69.4K ﹤0.01% 4448
2022
Q2 		$63K Sell
115
-50
-30% -$23.9K ﹤0.01% 3951
2022
Q1 		$105K Buy
+165
New +$64K ﹤0.01% 3756

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return